Results of the FIX-HF-5C study confirming the benefits of Impulse Dynamics NV's Optimizer cardiac contractility modulation (CCM) device on endpoints that are important to heart-failure patients, including exercise capacity and quality of life, while also demonstrating the system's potential to reduce heart-failure morbidity and mortality, according to principal investigator William Abraham of Ohio State University in Columbus, Ohio (US).
Specifically, 12- and 24-week follow-up data from FIX-HF-5C showed that Optimizer significantly improved exercise tolerance and quality of life in...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?